AI Summary & Key Takeaways
AI InsightTo adequately care for these patients, anesthesiologists should control complex malfunctions of physiologic mechanisms, such as hypo-hyperthermia, blood loss, electrolyte abnormalities, coagulopathies, increased cardiac index, oxygen consumption, decreased systemic vascular resistance and toxic effects of chemotherapy agents related with both longer duration of radical surgery and the effects of hyperthermic chemotheraphy.
📌 3 Key Takeaways
Abstract
The evolvings of alternative treatment choices as cytoreductive surgery combined with hyperthermic chemotherapy for peritoneal surface malignancies creates new responsibilities for anesthesiologists to manage the procedure with sufficient information. To adequately care for these patients, anesthesiologists should control complex malfunctions of physiologic mechanisms, such as hypo-hyperthermia, blood loss, electrolyte abnormalities, coagulopathies, increased cardiac index, oxygen consumption, decreased systemic vascular resistance and toxic effects of chemotherapy agents related with both longer duration of radical surgery and the effects of hyperthermic chemotheraphy.
Özet
Peritoneal yüzey maligniteleri için sitoredüktif cerrahi ve kombine hipertermik intraperitoneal kemoterapi ile alternatif tedavi seçeneklerindeki gelişmeler anestezistler için prosedürün yeterli bilgi ile yönetimi için yeni sorumluluklar oluşturmaktadır. Bu hastaları yeterli bakımı için anestezistler hipo-hipertermi, kan kaybı, elektrolit bozuklukları, koagülopatiler, artmış kardiyak indeks, oksijen tüketimi, azalmış sistemik vasküler rezistans ve kemoterapi ajanlarının toksik etkileri gibi hem uzun süreli radikal cerrahi hem de hipertermik kemoterapinin etkilerini içeren kompleks fizyolojik bozuklukları kontrol etmelidir.